Successful rheumatic therapy with biosimilars
Corporate film for Association Pro Generika
Rheumatism is a disease that has many faces. There are more than a hundred different clinical pictures. Often it is difficult to identify them clearly, but it is so important that a diagnosis is made quickly. Only then rheumatologists can start a personalized treatment. Biological medicines, so-called biopharmaceutical, play an important role in the therapy. They can delay the course of the disease and, above all, relieve pain.
Filming with a patient and rheumatologist in Berlin
For the working group Pro Biosimilars our film production produced a corporate film about the this subject in August and September. How do biosimilars, the replicas of biopharmaceutical, influence rheumatic diseases? We met a patient in Berlin who has been ill for more than twenty years. She told us impressively how the biosimilars changed her life. We also talked to her rheumatologist who has been prescribing biopharmaceutical and biosimilars for many years.
The use of biosimilars is very simple and can be used at home by any patient
Rheumatism patient Doreen Reimann can now even ride a bicycle again
Eventfilm on the pharmaceutical dialogue of the association Pro Generika
The association "Pro Generika e. V." was part of the pharmaceutical dialogue of the German Government and has committed itself to ideas and concepts. The results of the event and future plans were discussed at this event.
Supply Bottlenecks for essential antibiotics
Corporate film for the association Pro Generika, Berlin
Again and again, even in the case of essential medicines such as antibiotics, there are bottlenecks. What impact do they have on supply? Would it be possible to produce more antibiotics in Germany in future times in order to make supplies more secure? The film, which we produced for the association "Pro Generika e. V." tries to find answers.
10 years of biosimilars in Germany
Congress opening film for a Association
For 10 years, there have been biosimilars in Germany. How did the biosimilars prove their worth in health care? Time for a study commissioned by the Pro Biosimilars Working Group, which was presented at a symposium in September 2016. Basiliscus Production produced the opening film for the symposium.
Opening film for the symposium of the association Pro Biosimilars
In September 2015 Basiliscus Film produced the opening film for the symposium of the association Pro Biosimilars!
